Insider Transactions last 24 months for RenovoRx, Inc. - NSDQ: RNXT
| Transactions | |||
| All | Buy | Sell | Option Exercise |
Filer's Name |
Relationship/ Title |
Trans. Date |
Trans. Type |
Ownership Type |
Security Type |
Shares |
Price |
Trans. Value |
Total Shares Owned |
| Bagai Shaun | Chief Executive Officer | 08/25/2025 | AP | Direct | COM | 5,000 | $0.91 | $4,549.00 | 330,040 |
| Bagai Shaun | Chief Executive Officer | 08/22/2025 | AP | Direct | COM | 5,000 | $0.95 | $4,747.50 | 325,040 |
| Agah Ramtin | Chief Medical Officer | 06/05/2025 | AP | Direct | COM | 21,000 | $1.40 | $29,400.00 | 734,460 |
| Marton Laurence | Director | 05/02/2025 | AM | Direct | COM | 20,480 | $0.15 | $3,072.00 | 66,164 |
| Agah Ramtin | Chief Medical Officer | 04/22/2025 | DG | Direct | COM | 400,000 | $0.00 | $0.00 | 713,460 |
| Bagai Shaun | Chief Executive Officer | 04/15/2025 | AP | Direct | COM | 7,500 | $0.91 | $6,821.25 | 320,040 |
| Agah Ramtin | Chief Medical Officer | 04/15/2025 | AP | Direct | COM | 15,000 | $0.90 | $13,500.00 | 1,113,460 |
| Agah Ramtin | Chief Medical Officer | 04/11/2025 | AP | Direct | COM | 20,000 | $0.80 | $16,000.00 | 1,098,460 |
| Kocak Ron | VP Controller and PAO | 04/10/2025 | AP | Direct | COM | 6,500 | $0.79 | $5,135.00 | 12,595 |
| Bagai Shaun | Chief Executive Officer | 04/09/2025 | AP | Direct | COM | 10,000 | $0.83 | $8,300.00 | 312,540 |
| Agah Ramtin | Chief Medical Officer | 04/09/2025 | AP | Direct | COM | 30,000 | $0.81 | $24,399.00 | 1,078,460 |
| Kocak Ron | VP Controller and PAO | 04/09/2025 | AP | Direct | COM | 6,000 | $0.80 | $4,800.00 | 6,095 |
| Agah Ramtin | Chief Medical Officer | 04/08/2025 | AP | Direct | COM | 26,000 | $0.84 | $21,840.00 | 1,048,460 |
| Marton Laurence | Director | 04/08/2025 | AP | Direct | COM | 12,050 | $0.85 | $10,218.40 | 45,684 |
| Kocak Ron | VP Controller and PAO | 04/08/2025 | AP | Direct | COM | 95 | $0.80 | $76.00 | 95 |
| Bagai Shaun | Chief Executive Officer | 04/07/2025 | AP | Direct | COM | 10,000 | $0.83 | $8,300.00 | 302,540 |
| Macfarlane K. Angela | Director | 01/26/2024 | AP | Direct | COM | 40,983 | $0.00 | $0.00 | 40,983 |
| Marton Laurence | Director | 01/26/2024 | AP | Direct | COM | 8,196 | $0.00 | $0.00 | 33,634 |
| Bagai Shaun | Chief Executive Officer | 01/26/2024 | AP | Direct | COM | 40,983 | $0.00 | $0.00 | 292,540 |
| Spiegel Robert J. | Director | 01/26/2024 | AP | Direct | COM | 40,983 | $0.00 | $0.00 | 40,983 |
| Agah Ramtin | Chief Medical Officer | 01/26/2024 | AP | Direct | COM | 40,983 | $0.00 | $0.00 | 47,460 |
| Nelms Angela | Chief Operating Officer | 10/03/2023 | AP | Direct | COM | 800 | $1.05 | $836.00 | 1,100 |
| Nelms Angela | Chief Operating Officer | 10/03/2023 | AP | Direct | COM | 300 | $1.05 | $314.97 | 300 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel | |||||||
© 2000 - 2025 Zacks Investment Research